Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Risk of ischemic stroke during the initiation period of α-blocker therapy among older men.

Lai CL, Kuo RN, Chen HM, Chen MF, Chan KA, Lai MS.

CMAJ. 2016 Mar 1;188(4):255-60. doi: 10.1503/cmaj.150624. Epub 2015 Dec 7.

2.

Clinical outcomes in low risk coronary artery disease patients treated with different limus-based drug-eluting stents--a nationwide retrospective cohort study using insurance claims database.

Lai CL, Wu CF, Kuo RN, Yang YY, Chen MF, Chan KA, Lai MS.

PLoS One. 2015 Apr 7;10(4):e0122860. doi: 10.1371/journal.pone.0122860. eCollection 2015.

3.

Early life exposure to undernutrition induces ER stress, apoptosis, and reduced vascularization in ovaries of adult rat offspring.

Chan KA, Bernal AB, Vickers MH, Gohir W, Petrik JJ, Sloboda DM.

Biol Reprod. 2015 Apr;92(4):110. doi: 10.1095/biolreprod.114.124149. Epub 2015 Mar 25.

4.

Pregnancy-associated breast cancer in Taiwanese women: potential treatment delay and impact on survival.

Yang YL, Chan KA, Hsieh FJ, Chang LY, Wang MY.

PLoS One. 2014 Nov 21;9(11):e111934. doi: 10.1371/journal.pone.0111934. eCollection 2014.

5.

Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.S.

Ascioglu S, Chan KA.

PLoS One. 2014 Jan 10;9(1):e83658. doi: 10.1371/journal.pone.0083658. eCollection 2014.

6.

Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic.

Brown JS, Petronis KR, Bate A, Zhang F, Dashevsky I, Kulldorff M, Avery TR, Davis RL, Chan KA, Andrade SE, Boudreau D, Gunter MJ, Herrinton L, Pawloski PA, Raebel MA, Roblin D, Smith D, Reynolds R.

Pharmaceutics. 2013 Mar 14;5(1):179-200. doi: 10.3390/pharmaceutics5010179.

7.

A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs.

Funch D, Gydesen H, Tornøe K, Major-Pedersen A, Chan KA.

Diabetes Obes Metab. 2014 Mar;16(3):273-5. doi: 10.1111/dom.12230. Epub 2013 Nov 26.

8.
9.

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.

Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, Uratsu C, Go AS, Sidney S, Nguyen-Huynh MN, Ray WA, Selby JV.

JAMA. 2011 Dec 28;306(24):2673-83. doi: 10.1001/jama.2011.1830. Epub 2011 Dec 12.

10.

ADHD drugs and serious cardiovascular events in children and young adults.

Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA.

N Engl J Med. 2011 Nov 17;365(20):1896-904. doi: 10.1056/NEJMoa1110212. Epub 2011 Nov 1.

11.

Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection.

Wang JL, Chang CH, Young-Xu Y, Chan KA.

Antimicrob Agents Chemother. 2010 Jun;54(6):2409-19. doi: 10.1128/AAC.01657-09. Epub 2010 Mar 22.

12.

Medication adherence and use of generic drug therapies.

Briesacher BA, Andrade SE, Fouayzi H, Chan KA.

Am J Manag Care. 2009 Jul;15(7):450-6.

13.

Pooling overdispersed binomial data to estimate event rate.

Young-Xu Y, Chan KA.

BMC Med Res Methodol. 2008 Aug 19;8:58. doi: 10.1186/1471-2288-8-58.

14.

Comparison of drug adherence rates among patients with seven different medical conditions.

Briesacher BA, Andrade SE, Fouayzi H, Chan KA.

Pharmacotherapy. 2008 Apr;28(4):437-43. doi: 10.1592/phco.28.4.437.

15.

Adverse events associated with prolonged antibiotic use.

Meropol SB, Chan KA, Chen Z, Finkelstein JA, Hennessy S, Lautenbach E, Platt R, Schech SD, Shatin D, Metlay JP.

Pharmacoepidemiol Drug Saf. 2008 May;17(5):523-32. doi: 10.1002/pds.1547.

16.

Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose.

Lin ND, Kleinman K, Chan KA, Yu XJ, France EK, Wei F, Mullooly JP, Black S, Shay DK, Kolczak M, Lieu TA; Vaccine Safety Datalink Team.

BMC Pediatr. 2006 Nov 13;6:31.

17.

Sex differences in gout epidemiology: evaluation and treatment.

Harrold LR, Yood RA, Mikuls TR, Andrade SE, Davis J, Fuller J, Chan KA, Roblin D, Raebel MA, Von Worley A, Platt R, Saag KG.

Ann Rheum Dis. 2006 Oct;65(10):1368-72. Epub 2006 Apr 27.

18.

Laboratory monitoring of drugs at initiation of therapy in ambulatory care.

Raebel MA, Lyons EE, Andrade SE, Chan KA, Chester EA, Davis RL, Ellis JL, Feldstein A, Gunter MJ, Lafata JE, Long CL, Magid DJ, Selby JV, Simon SR, Platt R.

J Gen Intern Med. 2005 Dec;20(12):1120-6.

19.

Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants.

Lin ND, Kleinman K, Chan KA, Yu XJ, France EK, Xu S, Wei F, Mullooly J, Santoli J, Lieu TA; Vaccine Safety Datalink Group.

BMC Pediatr. 2005 Nov 28;5:43.

20.

The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative.

Newton KM, Buist DS, Miglioretti DL, Beverly K, Hartsfield CL, Chan KA, Andrade SE, Wei F, Connelly MT, Kessler L.

J Gen Intern Med. 2005 Apr;20(4):350-6.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk